Show
Sort by
-
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BMF AML Study Group and EWOG-MDS
-
Phase I study to evaluate dose, safety and tolerability of the polo-like kinase inhibitor Volasertib in paediatric patients with acute leukaemia and advanced solid tumours
-
The integrated immunological signature of Refractory Cytopenia of Childhood (RCC)
-
Long-term results of the 'Prospective study of the diagnosis and treatment of myelodysplastic syndromes in childhood (EWOG-MDS98)'
-
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS
-
- Journal Article
- A1
- open access
T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS
-
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood
-
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood
-
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood
-
The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood : a prospective study by EWOG-MDS